The resulting increase in hepatic DPP4 worsen NAFLD progression by disrupting insulin signaling through autocrine and paracrine mechanisms while decreasing GLP-1 levels (Baumeier et al., 2017b). Here, GCG is linked to metabolic dysfunction-associated steatotic liver disease.